The EU Commission announces the closure of its antitrust investigation in the pharmaceutical sector (Almirall / Boehringer)

L'Ecluse, Peter

Previous article The Dutch Competition Authority reconsiders abuse of a dominant position by a gas wholesale company (GasTerra) Next article The Italian Competition Authority fines a leading chemical company €5 M for refusal to grant access to research data (Bayer CropSciences)

6 Jul 2011

The EU Commission announces the closure of its antitrust investigation in the pharmaceutical sector (Almirall / Boehringer)

KEYWORDS

Reference

EU Commission, Almirall / Boehringer, Press Release, 6 July 2011

On 6 July 2011, the European Commission announced that it has closed its antitrust investigation into allegations by Spanish pharmaceutical company Almirall that the German pharmaceutical company Boehringer Ingelheim filed for unmeritous patents in the area of new treatments for lung diseases and, more specifically, new treatments of chronic obstructive pulmonary disease (“COPD”). Boehringer is the market leader in the

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

Peter L’Ecluse
Van Bael & Bellis (Brussels)

Belgium 125 contributions 35649 visits

Quotation

Peter L'Ecluse, The EU Commission announces the closure of its antitrust investigation in the pharmaceutical sector (Almirall / Boehringer), 6 July 2011, e-Competitions July 2011, Art. N° 41100

Visites 288